Just Protecting Prices of On-Patent Meds Would Lead to 1.3% Growth in Japan: PhRMA

PhRMA Japan Representative Hans Klemm Simply maintaining the prices of innovative medicines during the patent period alone would bring the Japanese pharma market back to growth, with an estimated annual growth rate of some 1.3%, according to the Pharmaceutical Research...read more